SkinBit

Early Skin Cancer detection for everyone

Print
Claim My Business
View on Wefunder
Security Type
CAFES
Categories
Technology, Financial Services, Healthcare & Medical
Min Investment
$250
Location
Los Angeles, , CA
No. Investors
612
Website
skinbit.co

Key Deal Facts

Repeat founders: CEO: 3 exits including Deezer ($1B+ IPO), Stanford Chief of Dermatology, Apple/Meta
$15B market: 98M Americans need annual skin screening, versus only 48M capacity today
Market validation: 4 LOI signed, representing 55,000 patients
Smart regulatory path: generate revenue immediately while building toward FDA autonomy
AI model built with 50,000 data points delivering +90% true positives and true negatives
Strong IP Protection with 2 patents issued and 1 pending
Annual screening requirements create a predictable, recurring revenue stream per patient

Management Team / Advisory Board Bios

Notable Angel
Raised $25k or more from a notable angel investor, Repeat Founder
Started a prior company with $2M+ in funding or revenue, Jonathan BenassayaFounder & CEOSerial entrepreneur & melanoma survivor. Founded Deezer (Euronext), StreamNation (acq. by SmugMug). Executive at Life360 & Meta. 20+ years building scalable consumer platforms & subscription models. Personal cancer experience fuels SkinBit's mission., Justin Ko, MDCo-Founder & Chief Medical AdvisorDr. Ko, Chief of Medical Dermatology at Stanford, brings unparalleled expertise in skin cancer diagnostics and AI innovation. His Nature-published research on AI in dermatology positions him at the forefront of the field., Manuel ColomCo-Founder & CXO20+ years UI/UX design including Apple lead designer. Serial entrepreneur translating complex medical tech into intuitive patient experiences. Human-centered design approach makes SkinBit's cancer detection accessible to all., Ilya NovoselskiyCo-Founder & AI LeadBiological sciences background, data science expert since 2018. Won prestigious 2024 ISIC dermatological imaging challenge. Computer vision specialist leading SkinBit's AI development for skin cancer detection., Bill Dower, PhDCo-Founder & Hardware LeadPhD synthetic aperture radar, University of Oklahoma. Led radar development at Raytheon, Epirus, Chaos Industries. High-resolution subsurface imaging expertise crucial for SkinBit's non-invasive cancer detection technology.
Amount Raised : $2,471,455
Reveal the Score by Voting
＿
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
ⓘ
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
ⓘ
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
ⓘ
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
ⓘ
The value of the company compared to similar companies raising money from investors.
Valuation

Security Description

A CAFES (Contract and Future Equity Stake) can convert into different types of equity upon a Triggering Event, such as: common or preferred stock for a corporation, limited partnership interest for a limited partnership and membership interest for a limited liability company. At the time of the Triggering Event, the specific rights and limitations associated with the equity stake being issued to the investors will be determined and disclosed by the Entrepreneur.

Research Reports

No reports have been submitted

Become a Reporter
Read Our Research Disclaimer

0 Comments

Post Comment